Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Perm Energy Supply Company approved dividends

1/9/25 PMSB

Shareholders of Zaymer approved dividends

1/9/25 ZAYM

Inter RAO acquired Mezhregionenergoservice

1/9/25 IRAO

PIK may completely withdraw from the project near the Tretyakov Gallery

1/9/25 PIKK

Segezha Group shareholders approved the additional share issue

12/28/24 SGZH

Promomed will continue to produce an analog of Ozempik

12/28/24 PRMD

Magnit shareholders did not approve dividends

12/28/24 MGNT

Sovcombank's nabsovet determined the price of share buyback from dissenters

12/28/24 SVCB

Binnopharm Group to enter the Iraqi market

12/28/24 AFKS

Shareholders of Diasoft approved dividends

12/28/24 DIAS